Search Results 81-90 of 10308 for cannabis

  1. 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression - Mayo Clinic

    Positive toxicology screen for cannabis and a cannabis use disorder by structured clinical interview for DSM-IV-TR. Participants who use cannabis for ...

  2. An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

    Patient is unwilling to abstain from using recreational or medicinal cannabis, or synthetic cannabinoid-based medications (including Sativex) during the study.

  3. Cyclic vomiting syndrome - Diagnosis & treatment - Mayo Clinic

    Do you or does your child use cannabis in any form? If so, how often? What you can do in the meantime. The doctor will likely want to see you or your child ...

  4. An Extension Study to Assess the Safety of the Use of Cannabidiol in Children and Young Adults with Dravet or Lennox-Gastaut Syndromes - Mayo Clinic

    Is currently using recreational or medicinal cannabis, or synthetic cannabinoid based medications (including Sativex®) other than the investigational ...

  5. Butalbital and acetaminophen combination (oral route) - Mayo Clinic

    Cannabis; Carbamazepine; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone; Clobazam ...

  6. Intensive tobacco treatment program - Overview - Mayo Clinic

    The use of tobacco, alcohol, and cannabis and other illegal substances is prohibited in this program. This includes during "off hours." After the program.

  7. Temazepam (oral route) - Mayo Clinic

    Bromopride; Buprenorphine; Butabarbital; Butalbital; Butorphanol; Calcium Oxybate; Cannabidiol; Cannabis; Carbidopa; Carbinoxamine; Carisoprodol; Cetirizine ...

  8. CBD products, hemp oil may be helpful but more research is needed, Mayo Clinic review says

    A review of the latest research, to be published in September in Mayo Clinic Proceedings, finds there's a growing body of preclinical and clinical evidence to ...

  9. A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) - Mayo Clinic

    Participant is currently using or has in the past used recreational or medicinal cannabis, or cannabinoid-based medications, within the 3 months prior to ...

  10. Flibanserin (oral route) - Mayo Clinic

    Cannabis; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone; Clobazam ...